ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

STERLING POTTER M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,956Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 586

$420K Total Retail Price of All Prescriptions

Rank: 44 out of 586

301 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 301 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

29% of this provider’s 301 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,489 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
HYDROCODONE-ACETAMINOPHEN 970 807 S3 1 5
FUROSEMIDE 472 454 2 9
SIMVASTATIN 402 370 3 1
POTASSIUM CHLORIDE 378 357 4 14
LEVOTHYROXINE SODIUM 347 321 5 2
LISINOPRIL 343 289 6 4
OMEPRAZOLE 343 315 6 3
AMLODIPINE BESYLATE 292 270 8 7
WARFARIN SODIUM 263 247 9 13
SERTRALINE HCL 229 208 10 21
GABAPENTIN 204 168 11 11
FENTANYL 171 154 S2 12 63
METOPROLOL SUCCINATE 169 160 13 19
LOSARTAN POTASSIUM 128 127 14 18
LANTUS 123 104 15 33
CARBIDOPA-LEVODOPA 119 88 16 89
OXYCODONE-ACETAMINOPHEN 115 101 S2 17 78
ZOLPIDEM TARTRATE 114 94 18 8
CITALOPRAM HBR 111 105 19 12
FLUOXETINE HCL 108 78 20 24
MORPHINE SULFATE 106 44 S2 21 189
PAROXETINE HCL 106 100 21 65
CYCLOBENZAPRINE HCL 99 37 R 23 60
OXYCODONE HCL 98 38 S2 24 32
ALLOPURINOL 97 84 25 35
ATORVASTATIN CALCIUM 90 72 26 17
GLYBURIDE 88 88 R 27 101
METFORMIN HCL ER 88 76 27 37
METOPROLOL TARTRATE 80 80 29 26
ATENOLOL 76 68 30 34
CEPHALEXIN 75 58 31 105
TRIAMTERENE-HCTZ 74 74 32 53
NOVOLOG 73 60 33 106
MELOXICAM 73 50 33 25
RISPERIDONE 71 61 35 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 39 36 16
METHYLPREDNISOLONE 62 50 37 144
PHENYTOIN SODIUM EXTENDED 61 34 38 132
DONEPEZIL HCL 57 57 39 40
DIVALPROEX SODIUM 56 56 40 69
MIRTAZAPINE 56 56 40 64
TRAMADOL HCL 56 54 40 15
DIGOXIN 55 55 43 96
CLOPIDOGREL 54 54 44 71
CARVEDILOL 54 53 44 30
OXYCODONE HCL-ACETAMINOPHEN 54 31 S2 44 55
OXYBUTYNIN CHLORIDE 54 54 44 83
METHADONE HCL 53 31 S2 48 93
HUMALOG 53 50 48 148
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.